Stereotactic body radiation therapy for stage I non-small cell lung cancer patients with chronic respiratory insufficiency requiring domiciliary oxygen therapy

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 4041-4044

  Yoshitake, Tadamasa ^a   Nakamura, Katsumasa ^a   Shioyama, Yoshiyuki ^a   Sasaki, Tomonari ^a   Ohga, Saiji ^a   Nonoshita, Takeshi ^a   Terashima, Kotaro ^a   Asai, Kaori ^a   Matsumoto, Keiji ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Chronic respiratory insufficiency; Domiciliary oxygen therapy; Non small cell lung cancer; Pulmonary adverse effects; Stereotactic body radiation therapy

Indexed keywords

OXYGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CHRONIC RESPIRATORY FAILURE; CLINICAL ARTICLE; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HOME CARE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; OVERALL SURVIVAL; OXYGEN THERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHRONIC DISEASE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OXYGEN INHALATION THERAPY; RADIOSURGERY; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 84867002828     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hiraoka M, Matsuo Y and Takayama K: Stereotactic body radiation therapy for lung cancer: Achievements and perspectives. Jpn J Clin Oncol 40 : 846-854, 2010.
2. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L and Lewensohn R: Outcome in a prospective phase II trial of medically inoperable stage I non-small- cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27: 3290-3296, 2009.
3. Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, Johansson KA, Ekberg L, Morhed E, Paludan M, Wittgren L, Blomgren H and Lewensohn R: Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45: 787-795, 2006.
4. Nyman J, Johansson KA and Hulten U: Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 51 : 97-103, 2006.
5. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E and Choy H: Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303: 1070-1076, 2010.
6. Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JS, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L and Lewensohn R: Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 88: 359-367, 2008.
7. McGarry RC, Song G, des Rosiers P and Timmerman R: Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest 121: 1155-1158, 2002.
8. Bishawi M, Kim B, Moore WH and Bilfinger TV: Pulmonary function testing after stereotactic body radiotherapy to the lung. Int J Radiat Oncol Biol Phys 82: e107-110, 2012.
9. Henderson M, McGarry R, Yiannoutsos C, Fakiris A, Hoopes D, Williams M and Timmerman R: Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 72: 404-409, 2008.
10. Shioyama Y, Nakamura K, Anai S, Sasaki T, Ooga S, Saku M, Urashima Y, Yoshitake T, Toba T, Terashima H and Honda H: Stereotactic radiotherapy for lung and liver tumors using a body cast system: Setup accuracy and preliminary clinical outcome. Radiat Med 23: 407-413, 2005.
11. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN and Rubin P: CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 : 176-181, 2003.
12. Nagata Y, Hiraoka M, Mizowaki T, Narita Y, Matsuo Y, Norihisa Y, Onishi H and Shirato H: Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys 75: 343-347, 2009.
13. Hiraoka M and Ishikura S: A Japan Clinical Oncology Group trial for stereotactic body radiation therapy of non-small cell lung cancer. J Thorac Oncol 2: S115-117, 2007.
14. Crockett AJ, Cranston JM, Moss JR and Alpers JH: Survival on long-term oxygen therapy in chronic airflow limitation: From evidence to outcomes in the routine clinical setting. Intern Med J 31: 448-454, 2001.
15. Shi A, Zhu G, Wu H, Yu R, Li F and Xu B: Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 5: 35, 2010.